Staflin, K., Zuch de Zafra, C. L., Schutt, L. K., Clark, V., Zhong, F., Hristopoulos, M., . . . Junttila, T. T. (2020). Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody. JCI Insight.
Style de citation ChicagoStaflin, Karin, et al. "Target Arm Affinities Determine Preclinical Efficacy and Safety of Anti-HER2/CD3 Bispecific Antibody." JCI Insight 2020.
Style de citation MLAStaflin, Karin, et al. "Target Arm Affinities Determine Preclinical Efficacy and Safety of Anti-HER2/CD3 Bispecific Antibody." JCI Insight 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.